The Clinical and Epidemiological Profile of Paediatric-Onset Multiple Sclerosis in Poland

Background. Paediatric-onset MS (POMS) has a unique clinical profile compared to the more prevalent adult-onset MS. For this study, we aimed to determine the demographic and clinical characteristics of POMS in Poland as well as addressing some of its epidemiological aspects. Methods. A retrospective study was conducted based on the Polish Multiple Sclerosis Registry, considering a population of children and adolescents with MS (age ≤ 18 years). Data were collected by all 13 centres across Poland specializing in diagnosing and treating POMS. The actual course of the disease and its clinical properties were compared between child (≤12 years) and juvenile (>12 years) patients. MS onset and its prevalence were assessed at the end of 2019, stratified by age range. Results. A total of 329 paediatric or juvenile patients (228 girls, 101 boys) with a clinically definite diagnosis of MS, in conformity with the 2017 McDonald Criteria, were enrolled. For 71 children (21.6%), the first symptoms appeared before the age of 12. The female: male ratio increased with age, amounting to 1:1 in the ≤12 years group and to 2.9:1 in the >12 years group. In most cases, the disease had multi-symptomatic onset (31.3%), and its course was mostly of a relapsing–remitting character (95.7%). The initial Expanded Disability Status Score for both groups was 1.63 ± 1.1, whereas the annual relapse rate was 0.84 during the first 2 years. The time between the onset of symptoms and diagnosis was longer in the younger patients (8.2 ± 4.2 vs. 4.6 ± 3.6 months; p < 0.005). On 31 December 2019, the age-adjusted prevalence standardized to the European standard population was 5.19/100,000 (95% CI, 4.64–5.78). Significantly higher prevalence was noted in the 13–18 years group (7.12; 95% CI, 6.64–7.86) than in the 9–12 years group (3.41; 95% CI, 2.98–3.86) and the <9 years group (0.56; 95% CI, 0.46–0.64; p < 0.001). Conclusion. POMS commencing at the age of ≤12 years is rare, differing significantly from the juvenile-onset and adult MS in terms of clinical characteristics, course, and incidence, as stratified by gender.

[1]  K. Kotulska,et al.  Pediatric-onset multiple sclerosis in Poland: A registry-based retrospective cohort study. , 2021, Multiple sclerosis and related disorders.

[2]  J. Hillert,et al.  Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study , 2021, Scientific Reports.

[3]  A. Słowik,et al.  Multiple sclerosis incidence and prevalence in Poland: Data from administrative health claims. , 2021, Multiple sclerosis and related disorders.

[4]  K. Dayasiri,et al.  Early-Onset Multiple Sclerosis With Frequent Relapses: A Challenging Diagnosis With a Less Favorable Prognosis , 2021, Cureus.

[5]  B. Steinborn,et al.  Pediatric multiple sclerosis - current status of epidemiology, diagnosis and treatment. , 2020, Neurologia i neurochirurgia polska.

[6]  E. Druyts,et al.  Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis. , 2020, Multiple sclerosis and related disorders.

[7]  J. Kochanowicz,et al.  The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland. , 2020, Multiple sclerosis and related disorders.

[8]  O. Ciccarelli,et al.  Paediatric multiple sclerosis: a new era in diagnosis and treatment , 2019, Developmental medicine and child neurology.

[9]  D. Oleske,et al.  Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature , 2019, Journal of child neurology.

[10]  M. Blinkenberg,et al.  Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977–2015: A nationwide population-based incidence study , 2018, Multiple sclerosis.

[11]  O. Ciccarelli,et al.  Multiple sclerosis , 2018, The Lancet.

[12]  Eliza M. Gordon-Lipkin,et al.  Pediatric Multiple Sclerosis in the United Arab Emirates: Characteristics From a Multicenter Study and Global Comparison , 2018, Journal of child neurology.

[13]  J. Kochanowicz,et al.  Prevalence of multiple sclerosis in Poland. , 2018, Multiple sclerosis and related disorders.

[14]  R. Alroughani,et al.  Pediatric multiple sclerosis: a review , 2018, BMC Neurology.

[15]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[16]  J. Takanashi,et al.  A nationwide survey of pediatric acquired demyelinating syndromes in Japan , 2016, Neurology.

[17]  J. Wolinsky,et al.  Consensus definitions for pediatric MS and other demyelinating disorders in childhood , 2016, Neurology.

[18]  Cody S. Olsen,et al.  Characteristics of Children and Adolescents With Multiple Sclerosis , 2016, Pediatrics.

[19]  Jonathan D. Campbell,et al.  Multiple sclerosis prevalence in the United States commercially insured population , 2016, Neurology.

[20]  S. Akhtar,et al.  Incidence and prevalence of pediatric onset multiple sclerosis in Kuwait: 1994–2013 , 2015, Journal of the Neurological Sciences.

[21]  J. Rosenbauer,et al.  Multiple sclerosis in children and adolescents: incidence and clinical picture – new insights from the nationwide German surveillance (2009–2011) , 2014, European journal of neurology.

[22]  T. Friede,et al.  Clinical presentation of pediatric multiple sclerosis before puberty , 2014, European journal of neurology.

[23]  A. Ghezzi,et al.  International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions , 2013, Multiple sclerosis.

[24]  B. Banwell,et al.  Pediatric Multiple Sclerosis , 2012, Journal of child neurology.

[25]  L. Meguins,et al.  Pediatric Multiple Sclerosis—A Challenging Demyelinating Disease: Case Report and Brief Review of the Literature , 2012, Case reports in pediatrics.

[26]  A. Achiron,et al.  Multiple sclerosis in Israeli children: incidence, an clinical, cerebrospinal fluid and magnetic resonance imaging findings. , 2012, The Israel Medical Association journal : IMAJ.

[27]  A. Sadovnick,et al.  Prevalence of multiple sclerosis. , 1982, Canadian Medical Association journal.

[28]  S. Sotgiu,et al.  Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy , 2015, European Journal of Pediatrics.

[29]  P. Vermersch,et al.  Natural history of multiple sclerosis with childhood onset. , 2007, The New England journal of medicine.